20
Participants
Start Date
June 1, 2022
Primary Completion Date
October 25, 2024
Study Completion Date
October 25, 2024
Tapering of inhaled corticosteroid (ICS) treatment
Tapering of ICS treatment over 8 weeks. Follow-up over 52 weeks in total. Dosis reduction of 50% in ICS treatment for 8 weeks, followed by total ICS removal. Other inhaled asthma medication remains unchanged during the entire study period.
Respiratory Research Unit, Copenhagen University Hospital Hvidovre, Hvidovre
Hvidovre University Hospital
OTHER